NHS deploys 3 new COVID drugs for vulnerable
The NHS is rolling out three groundbreaking COVID-19 treatments to protect the most vulnerable, including molnupiravir and ritonavir, offering new hope for high-risk patients across the UK.
The NHS is rolling out three groundbreaking COVID-19 treatments to protect the most vulnerable, including molnupiravir and ritonavir, offering new hope for high-risk patients across the UK.
The UK government has secured 250,000 courses of Merck's molnupiravir, an innovative antiviral pill shown to halve hospitalisations in a major scientific breakthrough.